One type of rapid diagnostic test (RDT) detects the presence of viral proteins (antigens) expressed by the COVID-19 virus in a sample from the respiratory tract of a person. If the target antigen is present in sufficient concentrations in the sample, it will bind to specific antibodies fixed to a paper strip enclosed in a plastic casing and generate a visually detectable signal, typically within 30 minutes. The antigen(s) detected are expressed only when the virus is actively replicating; therefore, such tests are best used to identify acute or early infection.
Due to the COVID-19 pandemic, the global COVID-19 Antigen Testing Kits market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe COVID-19 Antigen Testing Kits market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe COVID-19 Antigen Testing Kits landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
PCR accounting for % of the COVID-19 Antigen Testing Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of COVID-19 Antigen Testing Kits include Roche Diagnostics, Thermo Fisher Scientific, Abbot Laboratories, BD, Biotec Biomedical, Co-Diagostics, ELITech Group, Primerdesign and Sansure Biotech, etc. In terms of revenue, the global 3 largest players have a % market share of COVID-19 Antigen Testing Kits in 2021.
This report focuses on COVID-19 Antigen Testing Kits volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall COVID-19 Antigen Testing Kits market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global COVID-19 Antigen Testing Kits Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
PCR
Qpcr
Segment by Application
Hospitals
Scientific Research
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche Diagnostics
Thermo Fisher Scientific
Abbot Laboratories
BD
Biotec Biomedical
Co-Diagostics
ELITech Group
Primerdesign
Sansure Biotech
Vazyme Medical
Kewei Diagnostics
SD Biosensor
CancerRop
LifeRiver
Gencurix
AssayGenie
Beijing Applied Biological
BioFire Defense
Daan Diagnostics
Chaozhou Hybribio
Getein Biotech
Kogene
Altona Diagnostics
Seegene
Wuxi Diagnostics
Seasun Biomaterials
GenoSensor